ザルトリウス・ジャパン Company Profile

Organoid technology requires reliable culture and analysis methods for applications in research and drug screening, and conventional methods face challenges due to limitations in the objective monitoring of 3D structures. In this regard, the organoid analysis application of the live cell analysis system Incucyte automates workflows, tracks and quantifies growth and morphology in real-time, and streamlines analysis and culture optimization, making it a powerful tool across a wide range of fields. In this seminar, we will present the latest information, including assay results using 96-well plates, in addition to the QC evaluation content introduced in the previous webinar. We will also explain the recognition and recovery methods for organoids using the automated cell imaging and picking device CellCelector, showcasing Sartorius's total solution that achieves an efficient workflow in combination with Incucyte. We look forward to your participation! Instructors: Sartorius Japan K.K. Takeshi Seguchi, Shohei Shimonishi Application deadline: November 7, 2025 (Friday) by 17:00.

In recent years, particularly due to the outbreak of the novel coronavirus, there has been a strong demand for the rapid development of vaccines, diagnostic methods, and research on therapeutic drugs for infectious disease control. To accelerate the development of therapeutic drugs and vaccines, high-throughput screening from many candidates and analytical instruments capable of more accurate and rapid characterization are necessary. The Octet system can measure binding interactions between biomolecules in unpurified samples. With its unique BLI technology and the design of instruments that allow simultaneous measurement of multiple samples, it enables high-throughput screening of candidate molecules, evaluation of binding characteristics, and concentration measurement. It is widely used not only in the development of therapeutic drugs and vaccines but also in research on fundamental infection mechanisms. In this seminar, we will introduce examples of the application of the Octet biomolecular interaction analysis system in the research and development of therapeutic drugs and vaccines, as well as research cases that contribute to understanding fundamental infection mechanisms. We hope you will join us! Instructor: Sartorius Japan K.K. Yusuke Maruyama Application deadline: By 17:00 on November 14, 2025 (Friday)

Sartorius Japan will hold "Pharma Xchange 2025" with the theme of the latest trends in pharmaceutical quality control (QC) and compliance measures. This seminar will deepen the understanding of regulatory requirements and introduce specific support measures for ethical practices across the industry. In addition to a lecture by Dr. Yukihiro Goda, a demonstration of Sartorius QC solutions is also planned. We look forward to your participation! Event Overview: Date: October 17, 2025 (Friday) 13:30 - 18:30 Venue: Station Conference Tokyo, Sapia Tower 6th Floor 1-7-12 Marunouchi, Chiyoda-ku, Tokyo 100-0005, directly connected to JR Tokyo Station Nihonbashi Exit Participation Fee: Free Eligibility: Individuals belonging to the pharmaceutical quality control department, engaged in related work, or interested in JP revisions. *Up to two participants per department from each company will be accepted on a first-come, first-served basis. If you wish to participate, you can apply using the form at the bottom of the details and application page. *Due to limited seating, please apply by September 22, 2025 (Monday).